Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer (Q39036253)

8 September 2017

1 reference

title

Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer (English)

1 reference

single-nucleotide polymorphism

8 September 2017

1 reference

1 reference

based on heuristic

inferred from title

author

Jennifer E Hardingham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Miriam Canavese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Doan T M Ngo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Guy J Maddern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Timothy J Price

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

10 December 2016

1 reference

International Journal of Cancer

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

2183-2191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

cites work

Cancer statistics, 2008

1 reference

Molecular mechanisms of liver metastasis

21 January 2018

1 reference

Invasive therapy of metastatic colorectal cancer to the liver

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2005

1 reference

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer

21 January 2018

1 reference

Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.

21 January 2018

1 reference

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy.

21 January 2018

1 reference

Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site

21 January 2018

1 reference

Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer

21 January 2018

1 reference

WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing

21 January 2018

1 reference

Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

21 January 2018

1 reference

Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.

21 January 2018

1 reference

Isolation and characterization of human anti-VEGF165 monoclonal antibody with anti-tumor efficacy from transgenic mice expressing human immunoglobulin loci

21 January 2018

1 reference

VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.

21 January 2018

1 reference

Targeted therapies in metastatic colorectal cancer: a systematic review and assessment of currently available data

21 January 2018

1 reference

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, doubl

21 January 2018

1 reference

VEGF as a therapeutic target in cancer

21 January 2018

1 reference

Angiogenesis as a therapeutic target

21 January 2018

1 reference

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo

21 January 2018

1 reference

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment

21 January 2018

1 reference

Angiogenesis in health and disease

21 January 2018

1 reference

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

Transcriptional regulation of the VEGF gene in dependence of individual genomic variations

21 January 2018

1 reference

A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels

21 January 2018

1 reference

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

21 January 2018

1 reference

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.

21 January 2018

1 reference

Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer

21 January 2018

1 reference

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis

21 January 2018

1 reference

Candidate gene case-control association studies: advantages and potential pitfalls

21 January 2018

1 reference

Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma

21 January 2018

1 reference

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

21 January 2018

1 reference

Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer

21 January 2018

1 reference

Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab

21 January 2018

1 reference

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

21 January 2018

1 reference

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab

21 January 2018

1 reference

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer

21 January 2018

1 reference

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

21 January 2018

1 reference

Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.

21 January 2018

1 reference

Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis

21 January 2018

1 reference

An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

21 January 2018

1 reference

Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity

21 January 2018

1 reference

Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancer

21 January 2018

1 reference

Therapeutic potential of manipulating VEGF splice isoforms in oncology

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

21 January 2018

1 reference

Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab

21 January 2018

1 reference

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.

21 January 2018

1 reference

VEGF-A splicing: the key to anti-angiogenic therapeutics?

21 January 2018

1 reference

Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension.

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

21 January 2018

1 reference

Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancer

21 January 2018

1 reference

Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance

21 January 2018

1 reference

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

21 January 2018

1 reference

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy

21 January 2018

1 reference

The anti-angiogenic isoforms of VEGF in health and disease

21 January 2018

1 reference

Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non-Small Cell Lung Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30567

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27943279%20AND%20SRC:MED&resulttype=core&format=json